Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-07-05

FDA Approved: HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE — Supplemental Application (KVK-Tech, Inc.)

View source ↗

Summary

FDA approved a supplemental application for hydrocodone bitartrate and homatropine methylbromide oral solution from KVK-Tech, Inc. (ANDA 207487).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE ORAL SOLUTION (hydrocodone bitartrate and homatropine methylbromide oral solution)

Snippet

SUPPL AP for HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE (HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE ORAL SOLUTION)